{"title":"抗- e、抗-c抗体不规律致反复妊娠1例分析。","authors":"Haijuan Wang, Jian Chen, Guojin Ou","doi":"10.7754/Clin.Lab.2025.250103","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Blood group irregular antibody is a major factor that may cause adverse pregnancy outcomes. We aimed to emphasize the importance of prenatal blood antibody screening and popularize antenatal care knowledge by sharing a case of hydrops fetalis caused by anti-E and anti-c alloimmunization antibodies.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical and laboratory data of a pregnant woman with repeated fetal edema caused by anti-E and anti-c irregular antibodies. Irregular antibody screening, antibody identification, and antibody titer detection were performed.</p><p><strong>Results: </strong>A pregnant woman aged 30 years old, in whom hydrops fetalis was found by color Doppler ultrasound at 32 + 5 gestation weeks. Irregular antibody screening was positive and anti-E and anti-c were detected in plasma. The results were negative by saline method. Antibody titers of anti-E and anti-c were 1,024 and 128, respectively, and Rh blood group was CCDee (R1R1). Eventually, a fatal termination had to be chosen for serious hydrops fetalis.</p><p><strong>Conclusions: </strong>Hydrops fetalis, stillborn fetus, and kernicterus are the severest outcomes of hemolytic disease of the fetus and newborn (HDFN). Anti-E and anti-c are common alloantibodies that lead to adverse fetal outcomes. Such adverse pregnancy outcomes can be minimized by improving pregnant women's awareness of HDFN and reinforcing the management of irregular blood group antibodies during pregnancy.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 7","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Case Analysis of a Repeated Hydrops Fetalis Caused by Irregular Antibodies of Anti-E and Anti-c.\",\"authors\":\"Haijuan Wang, Jian Chen, Guojin Ou\",\"doi\":\"10.7754/Clin.Lab.2025.250103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Blood group irregular antibody is a major factor that may cause adverse pregnancy outcomes. We aimed to emphasize the importance of prenatal blood antibody screening and popularize antenatal care knowledge by sharing a case of hydrops fetalis caused by anti-E and anti-c alloimmunization antibodies.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical and laboratory data of a pregnant woman with repeated fetal edema caused by anti-E and anti-c irregular antibodies. Irregular antibody screening, antibody identification, and antibody titer detection were performed.</p><p><strong>Results: </strong>A pregnant woman aged 30 years old, in whom hydrops fetalis was found by color Doppler ultrasound at 32 + 5 gestation weeks. Irregular antibody screening was positive and anti-E and anti-c were detected in plasma. The results were negative by saline method. Antibody titers of anti-E and anti-c were 1,024 and 128, respectively, and Rh blood group was CCDee (R1R1). Eventually, a fatal termination had to be chosen for serious hydrops fetalis.</p><p><strong>Conclusions: </strong>Hydrops fetalis, stillborn fetus, and kernicterus are the severest outcomes of hemolytic disease of the fetus and newborn (HDFN). Anti-E and anti-c are common alloantibodies that lead to adverse fetal outcomes. Such adverse pregnancy outcomes can be minimized by improving pregnant women's awareness of HDFN and reinforcing the management of irregular blood group antibodies during pregnancy.</p>\",\"PeriodicalId\":10384,\"journal\":{\"name\":\"Clinical laboratory\",\"volume\":\"71 7\",\"pages\":\"\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical laboratory\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7754/Clin.Lab.2025.250103\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2025.250103","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
Case Analysis of a Repeated Hydrops Fetalis Caused by Irregular Antibodies of Anti-E and Anti-c.
Background: Blood group irregular antibody is a major factor that may cause adverse pregnancy outcomes. We aimed to emphasize the importance of prenatal blood antibody screening and popularize antenatal care knowledge by sharing a case of hydrops fetalis caused by anti-E and anti-c alloimmunization antibodies.
Methods: We retrospectively analyzed the clinical and laboratory data of a pregnant woman with repeated fetal edema caused by anti-E and anti-c irregular antibodies. Irregular antibody screening, antibody identification, and antibody titer detection were performed.
Results: A pregnant woman aged 30 years old, in whom hydrops fetalis was found by color Doppler ultrasound at 32 + 5 gestation weeks. Irregular antibody screening was positive and anti-E and anti-c were detected in plasma. The results were negative by saline method. Antibody titers of anti-E and anti-c were 1,024 and 128, respectively, and Rh blood group was CCDee (R1R1). Eventually, a fatal termination had to be chosen for serious hydrops fetalis.
Conclusions: Hydrops fetalis, stillborn fetus, and kernicterus are the severest outcomes of hemolytic disease of the fetus and newborn (HDFN). Anti-E and anti-c are common alloantibodies that lead to adverse fetal outcomes. Such adverse pregnancy outcomes can be minimized by improving pregnant women's awareness of HDFN and reinforcing the management of irregular blood group antibodies during pregnancy.
期刊介绍:
Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.